Matches in Wikidata for { <http://www.wikidata.org/entity/Q62031550> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q62031550 description "clinical trial" @default.
- Q62031550 description "ensayu clínicu" @default.
- Q62031550 description "klinisch onderzoek" @default.
- Q62031550 description "клінічне випробування" @default.
- Q62031550 description "临床试验" @default.
- Q62031550 name "Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)" @default.
- Q62031550 type Item @default.
- Q62031550 label "Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)" @default.
- Q62031550 prefLabel "Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)" @default.
- Q62031550 P1132 Q62031550-6946BF6E-DF30-4A02-8315-3ED480721A97 @default.
- Q62031550 P1476 Q62031550-2373A1C5-3793-46D3-985A-2EA1D12F8446 @default.
- Q62031550 P2899 Q62031550-65105635-9963-4702-AD2E-5D6B2D9E7A3E @default.
- Q62031550 P3098 Q62031550-AEAC3FF9-2AD6-42AF-8529-7F1727E17DAD @default.
- Q62031550 P31 Q62031550-6FBA0932-F190-4CA6-B4D6-80849540C615 @default.
- Q62031550 P4135 Q62031550-AD6416AA-B879-4B79-B926-784FE76CBD72 @default.
- Q62031550 P4844 Q62031550-69BDF1F4-7942-4AE5-A451-13B5EDA1732E @default.
- Q62031550 P4844 Q62031550-880DAC31-CF41-45AD-B02E-715B79D7A6CD @default.
- Q62031550 P580 Q62031550-CA593CCC-3F00-4928-9B76-DA7D65B47A4C @default.
- Q62031550 P582 Q62031550-6399AABB-D3D0-4E10-A523-C14B37B34580 @default.
- Q62031550 P6099 Q62031550-EE72A6DC-7C80-48DD-B371-C7F60A3DEF5C @default.
- Q62031550 P8005 Q62031550-59A548D6-F75A-4A8C-B1E2-006CFCD742E1 @default.
- Q62031550 P8363 Q62031550-9F26E095-F3C4-4334-9AC2-F6B09B448F61 @default.
- Q62031550 P859 Q62031550-062FEF23-AD71-45DA-83E6-122EC02E44DA @default.
- Q62031550 P1132 "+450" @default.
- Q62031550 P1476 "A Phase 3 Randomized, Active-comparator-controlled Clinical Study to Evaluate the Efficacy and Safety of Ezetimibe/Atorvastatin Combination Tablet (MK-0653C) as Second Line Lipid Lowing Treatment in Chinese Participants" @default.
- Q62031550 P2899 "+18" @default.
- Q62031550 P3098 "NCT03768427" @default.
- Q62031550 P31 Q30612 @default.
- Q62031550 P4135 "+80" @default.
- Q62031550 P4844 Q27888052 @default.
- Q62031550 P4844 Q417997 @default.
- Q62031550 P580 "2019-05-28T00:00:00Z" @default.
- Q62031550 P582 "2021-02-28T00:00:00Z" @default.
- Q62031550 P6099 Q42824827 @default.
- Q62031550 P8005 Q76649708 @default.
- Q62031550 P8363 Q78089383 @default.
- Q62031550 P859 Q58219685 @default.